- Home
- ARTNA vs TERN Comparison
ARTNA vs TERN Comparison
Compare ARTNA & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTNA
- TERN
- Stock Information
- Founded
- ARTNA 1905
- TERN 2017
- Country
- ARTNA United States
- TERN United States
- Employees
- ARTNA N/A
- TERN N/A
- Industry
- ARTNA Water Supply
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- ARTNA Utilities
- TERN Health Care
- Exchange
- ARTNA Nasdaq
- TERN Nasdaq
- Market Cap
- ARTNA 336.7M
- TERN 310.8M
- IPO Year
- ARTNA 1996
- TERN 2021
- Fundamental
- Price
- ARTNA $32.54
- TERN $2.78
- Analyst Decision
- ARTNA
- TERN Buy
- Analyst Count
- ARTNA 0
- TERN 5
- Target Price
- ARTNA N/A
- TERN $15.63
- AVG Volume (30 Days)
- ARTNA 36.4K
- TERN 996.2K
- Earning Date
- ARTNA 05-05-2025
- TERN 05-08-2025
- Dividend Yield
- ARTNA 3.72%
- TERN N/A
- EPS Growth
- ARTNA 22.05
- TERN N/A
- EPS
- ARTNA 2.08
- TERN N/A
- Revenue
- ARTNA $109,294,000.00
- TERN N/A
- Revenue This Year
- ARTNA $6.86
- TERN N/A
- Revenue Next Year
- ARTNA $2.68
- TERN N/A
- P/E Ratio
- ARTNA $15.59
- TERN N/A
- Revenue Growth
- ARTNA 8.31
- TERN N/A
- 52 Week Low
- ARTNA $29.45
- TERN $1.87
- 52 Week High
- ARTNA $41.29
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- ARTNA 39.67
- TERN 44.33
- Support Level
- ARTNA $34.01
- TERN $2.93
- Resistance Level
- ARTNA $35.03
- TERN $3.40
- Average True Range (ATR)
- ARTNA 1.16
- TERN 0.25
- MACD
- ARTNA -0.33
- TERN -0.02
- Stochastic Oscillator
- ARTNA 8.06
- TERN 5.62
About ARTNA Artesian Resources Corporation
Artesian Resources Corp operates as a holding company with a focus on water distribution and wastewater services. Its regulated utility segment includes subsidiaries providing water and wastewater services in Delaware, Maryland, and Pennsylvania. Water distribution spans residential, commercial, industrial, and municipal sectors, while wastewater services are offered primarily in Sussex County, Delaware. The company also engages in non-utility businesses, offering service line protection plans, engineering services, and contract operations for water and wastewater systems. The regulated utility segment constitutes the largest portion of the company's operations, subject to regulations by Delaware, Maryland, and Pennsylvania.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.